The Different Roles of MET in the Development and Treatment of Cancer

por Mollerup, Jens, Jørgensen, Jan Trøst
Publicado 2023

Companion Diagnostics and Predictive Biomarkers for MET-Targeted Therapy in NSCLC

por Jørgensen, Jan Trøst, Mollerup, Jens
Publicado 2022

Dual color chromogenic in situ hybridization for determination of HER2 status in breast cancer: a large comparative study to current state of the art fluorescence in situ hybridiza...

por Mollerup, Jens, Henriksen, Ulla, Müller, Sven, Schønau, Andreas
Publicado 2012

Gene Signal Distribution and HER2 Amplification in Gastroesophageal Cancer

por Jørgensen, Jan Trøst, Nielsen, Karsten Bork, Kjærsgaard, Gitte, Jepsen, Anna, Mollerup, Jens
Publicado 2017

MET deletion is a frequent event in gastric/gastroesophageal junction/esophageal cancer: a cross-sectional analysis of gene status and signal distribution in 1,580 patients

por Jørgensen, Jan Trøst, Mollerup, Jens, Yang, Hui, Go, Ning, Nielsen, Karsten Bork
Publicado 2021

A Companion Diagnostic With Significant Clinical Impact in Treatment of Breast and Gastric Cancer

por Jørgensen, Jan Trøst, Winther, Henrik, Askaa, Jon, Andresen, Lena, Olsen, Dana, Mollerup, Jens
Publicado 2021

The calcium binding protein ALG-2 binds and stabilizes Scotin, a p53-inducible gene product localized at the endoplasmic reticulum membrane

por Dræby, Ingrid, Woods, Yvonne L., la Cour, Jonas M., Mollerup, Jens, Bourdon, Jean-Christophe, Berchtold, Martin W.
Publicado 2007

Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European mul...

por García-Caballero, Tomás, Grabau, Dorthe, Green, Andrew R, Gregory, John, Schad, Arno, Kohlwes, Elke, Ellis, Ian O, Watts, Sarah, Mollerup, Jens
Publicado 2010